A phase II study of pembrolizumab (P) in combination with doxorubicin (D) in advanced endometrial cancer (AEC): TOPIC trial/VHIO10001
No Thumbnail Available
Identifiers
Date
2021-09-21
Authors
Farinas-Madrid, L.
Rubio, M. J.
Redondo, A.
Villacampa Javierre, G.
Yubero Esteban, A.
Romero, I.
Gil-Martin, M.
Garcia-Donas, J.
Gonzalez-Martin, A.
Gallego Martinez, A.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier